The Oncology Institute, Inc. Stock

Equities

TOI

US68236X1000

Healthcare Facilities & Services

End-of-day quote Nasdaq 06:00:00 2024-05-14 pm EDT 5-day change 1st Jan Change
0.684 USD -24.00% Intraday chart for The Oncology Institute, Inc. -26.45% -66.47%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 415M Sales 2025 * 483M Capitalization 47.49M
Net income 2024 * -54M Net income 2025 * -35M EV / Sales 2024 * 0.11 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.1 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 800
Yield 2024 *
-
Yield 2025 *
-
Free-Float 66.98%
More Fundamentals * Assessed data
Dynamic Chart
1 day-24.00%
1 week-26.45%
Current month-35.47%
1 month-41.54%
3 months-64.92%
6 months-70.33%
Current year-66.47%
More quotes
1 week
0.62
Extreme 0.6202
0.91
1 month
0.62
Extreme 0.6202
1.29
Current year
0.62
Extreme 0.6202
2.50
1 year
0.33
Extreme 0.33
2.66
3 years
0.33
Extreme 0.33
12.66
5 years
0.33
Extreme 0.33
12.66
10 years
0.33
Extreme 0.33
12.66
More quotes
Managers TitleAgeSince
Chief Executive Officer 46 18-12-31
Director of Finance/CFO 45 22-04-03
Chief Operating Officer 41 23-09-04
Members of the board TitleAgeSince
Chairman 70 21-11-11
Director/Board Member 68 22-09-20
Director/Board Member 45 18-12-31
More insiders
Date Price Change Volume
24-05-17 0.639 -5.08% 328,642
24-05-16 0.6732 -1.58% 212,879
24-05-15 0.684 -24.00% 852,128
24-05-14 0.9 +3.54% 147,589
24-05-13 0.8692 -6.54% 224,468

End-of-day quote Nasdaq, May 14, 2024

More quotes
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. It also provides management services to 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.639 USD
Average target price
2 USD
Spread / Average Target
+212.99%
Consensus

Quarterly revenue - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW